+1 650 797 2003 contact@chempartner.com
  • Careers
  • Contact Us
ChemPartner
  • About
    • About ChemPartner
    • CRO Services
    • CDMO Services
    • Awards & Accolades
    • Publications
  • Services
    • Discovery Chemistry
    • Biology & Pharmacology
    • DMPK / Exploratory Toxicology
    • Biologics Discovery
    • Biologics CMC
    • Small Molecule CMC
  • News
    • Latest News
    • Events
    • Webinars
  • Blog
  • Resource Center
Select Page
Innovations in Lead Generation Through Fragment-Based Screening

Innovations in Lead Generation Through Fragment-Based Screening

by Eric Eschmann | Mar 12, 2021 | Uncategorized

When it comes to finding new chemical matter to engage biological targets, fragment-based screening (FBS) offers a number of advantages over traditional high-throughput screening (HTS). The success of this approach has resulted in a growing list of molecules advancing...

Recent Posts

  • How Is Remdesivir Made?
  • Discovery of the Hepatitis C Virus — The 2020 Nobel Prize in Physiology or Medicine
  • How Does Remdesivir Work?
  • Meeting Chiral Separation Efficiency Needs in Pharmaceutical Discovery with Supercritical Fluid Chromatography

Tags

B Cell Cloning Biologics Biologics Discovery Chemistry Chromatography COVID-19 Drug Development Drug Discovery Fragment-Based Screening (FBS) General Nobel Prize Virus
  • Careers
  • Contact Us
©2022 Shanghai ChemPartner